Lantheus Medical files registration forms ahead of an initial public offering worth up to $125 million in support of its diagnostic and imaging products.
Massachusetts-based Lantheus Medical Imaging announced today that it filed registration documents ahead of launching an initial public offering.
The company, which makes imaging agents and other diagnostic products, has yet to reveal share pricing or quantity, but set the maximum aggregate offering price at $125 million. Lantheus deals primarily in radiopharmaceutical and contrast agents, according to the prospectus summary.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1pPtduE
Cap comentari:
Publica un comentari a l'entrada